UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.06B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$590M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$368M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$264M |
| 5 |
UBS Group
UBS
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$717M |
| 2 |
Microsoft
MSFT
|
+$677M |
| 3 |
Apple
AAPL
|
+$653M |
| 4 |
Amazon
AMZN
|
+$641M |
| 5 |
Meta Platforms (Facebook)
META
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.23% |
| 2 | Financials | 6.63% |
| 3 | Healthcare | 5.96% |
| 4 | Consumer Discretionary | 5.78% |
| 5 | Industrials | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$432M
| $3.09M | ﹤0.01% |
26,587
-4,331
| -14% | -$488K |
|
3327
QuidelOrtho
QDEL
$943M
| $3.08M | ﹤0.01% |
22,826
-7,326
| -24% | -$1.02M |
|
3328
Syndax Pharmaceuticals
SNDX
$1.82B
| $3.08M | ﹤0.01% |
140,517
+70,004
| +99% | +$1.29M |
|
3329
Beam Therapeutics
BEAM
$2.82B
| $3.08M | ﹤0.01% |
38,584
-10,167
| -21% | -$871K |
|
3330
Xencor
XNCR
$1.6B
| $3.07M | ﹤0.01% |
76,607
+26,507
| +53% | +$1M |
|
3331
Rocket Pharmaceuticals
RCKT
$397M
| $3.07M | ﹤0.01% |
140,732
+44,829
| +47% | +$1.22M |
|
3332
Telefônica Brasil
VIV
$19.1B
| $3.07M | ﹤0.01% |
355,207
-339,785
| -49% | -$2.9M |
|
|
PDM
3333
Piedmont Realty Trust
PDM
$1.16B
| $3.07M | ﹤0.01% |
166,989
-41,068
| -20% | -$752K |
|
|
SGMO
3334
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $3.06M | ﹤0.01% |
408,412
+118,557
| +41% | +$1.03M |
|
3335
CALL
Marvell Technology
MRVL
$187B
| $3.06M | ﹤0.01% |
+35,000
| New | +$2.61M |
|
3336
uniQure
QURE
$3.2B
| $3.06M | ﹤0.01% |
147,629
+100,777
| +215% | +$2.89M |
|
|
ELME
3337
Elme Communities
ELME
$144M
| $3.06M | ﹤0.01% |
118,414
-66,830
| -36% | -$1.71M |
|
3338
Fidelity Dividend ETF for Rising Rates
FDRR
$761M
| $3.06M | ﹤0.01% |
67,476
+747
| +1% | +$32.6K |
|
3339
Western Union
WU
$2.19B
| $3.06M | ﹤0.01% |
171,495
+118,328
| +223% | +$2.18M |
|
|
KNBE
3340
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $3.06M | ﹤0.01% |
133,380
+91,987
| +222% | +$2.16M |
|
3341
Eastern Bankshares
EBC
$5.24B
| $3.06M | ﹤0.01% |
151,523
+71,264
| +89% | +$1.48M |
|
|
DBL
3342
DoubleLine Opportunistic Credit Fund
DBL
$281M
| $3.05M | ﹤0.01% |
159,257
-8,672
| -5% | -$167K |
|
3343
CALL
Moderna
MRNA
$23.9B
| $3.05M | ﹤0.01% |
12,000
+2,000
| +20% | +$585K |
|
|
GRP.U
3344
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $3.04M | ﹤0.01% |
36,555
+6,320
| +21% | +$498K |
|
3345
Invesco BulletShares 2028 Municipal Bond ETF
BSMS
$316M
| $3.04M | ﹤0.01% |
116,015
+365
| +0.3% | +$9.53K |
|
3346
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.59B
| $3.04M | ﹤0.01% |
140,886
+22,725
| +19% | +$491K |
|
3347
PUT
Eastman Chemical
EMN
$8.39B
| $3.04M | ﹤0.01% |
25,100
-14,900
| -37% | -$1.66M |
|
3348
FirstCash
FCFS
$9.05B
| $3.02M | ﹤0.01% |
40,371
+35,096
| +665% | +$2.7M |
|
|
JHS
3349
John Hancock Income Securities Trust
JHS
$127M
| $3.02M | ﹤0.01% |
196,071
+32,328
| +20% | +$501K |
|
3350
Enanta Pharmaceuticals
ENTA
$402M
| $3.02M | ﹤0.01% |
40,364
+9,159
| +29% | +$719K |
|
Similar funds
UBS Group's Q4 2021 Portfolio in Review
As of Q4 2021, UBS Group held 11,479 positions worth $349B, up 9.9% from $318B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q4 2021 filing shows 1,739 new, 5,110 increased, 3,129 reduced and 997 closed positions. Its largest new stake was Hertz: 1,027,564 shares worth $25.7M. The largest sale was iShares Russell 2000 ETF, an estimated $717M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2021 buy was Hertz: 1,027,564 shares worth $25.7M.
- UBS Group added most to iShares Core S&P 500 ETF in Q4 2021, an estimated $1.06B increase.
- UBS Group's biggest Q4 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $717M.
- UBS Group fully exited Kansas City Southern in Q4 2021, selling an estimated $81.9M.
- UBS Group's ten largest holdings make up 14% of its $349B portfolio in Q4 2021.
- UBS Group opened 1,739 new positions and closed 997 in Q4 2021.
- UBS Group's portfolio value rose 9.9% quarter-over-quarter to $349B.
Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.